{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:53:53Z","timestamp":1790870033400,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1136\/ard.2004.035063","type":"journal-article","created":{"date-parts":[[2005,5,6]],"date-time":"2005-05-06T20:18:26Z","timestamp":1115410706000},"page":"1677-1684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy"],"prefix":"10.1016","volume":"64","author":[{"given":"J","family":"Adriaansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S W","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L","family":"Klarenbeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A C","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Apparailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G S","family":"Firestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J B M","family":"Vervoordeldonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P P","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2004.035063_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1699-0463.1997.tb00567.x","article-title":"TNF blockade in rheumatoid arthritis: implications for therapy and pathogenesis","volume":"105","author":"Maini","year":"1997","journal-title":"APMIS"},{"key":"10.1136\/ard.2004.035063_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P","article-title":"A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores","volume":"43","author":"Jiang","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.035063_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM199707173370301","article-title":"Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein","volume":"337","author":"Moreland","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2004.035063_bib4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0140-6736(94)90628-9","article-title":"Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"10.1136\/ard.2004.035063_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00541375","article-title":"Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67","volume":"7","author":"Lalor","year":"1987","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2004.035063_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1566523034578285","article-title":"From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy","volume":"3","author":"Grimm","year":"2003","journal-title":"Curr Gene Ther"},{"key":"10.1136\/ard.2004.035063_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/(SICI)1521-2254(199905\/06)1:3<166::AID-JGM34>3.0.CO;2-Z","article-title":"Adeno-associated virus-mediated gene delivery","volume":"1","author":"Snyder","year":"1999","journal-title":"J Gene Med"},{"key":"10.1136\/ard.2004.035063_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1529-0131(200002)43:2<289::AID-ANR8>3.0.CO;2-H","article-title":"Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist","volume":"43","author":"Pan","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.035063_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/mthe.2000.0111","article-title":"Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium","volume":"2","author":"Watanabe","year":"2000","journal-title":"Mol Ther"},{"key":"10.1136\/ard.2004.035063_bib10","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1089\/104303400750038525","article-title":"Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis","volume":"11","author":"Zhang","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1136\/ard.2004.035063_bib11","first-page":"983","article-title":"Empirical advantages of adeno-associated viral vectors in vivo gene therapy for arthritis","volume":"27","author":"Goater","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.035063_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/mthe.2002.0808","article-title":"Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product","volume":"6","author":"Chan","year":"2002","journal-title":"Mol Ther"},{"key":"10.1136\/ard.2004.035063_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.125.2.509","article-title":"Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial","volume":"125","author":"Moss","year":"2004","journal-title":"Chest"},{"key":"10.1136\/ard.2004.035063_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/10430340460732490","article-title":"Phase I trial of intramuscular injection of a recombinant adeno-associated virus alpha 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults","volume":"15","author":"Flotte","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1136\/ard.2004.035063_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1055\/s-2004-825639","article-title":"Clinical gene transfer studies for hemophilia B","volume":"30","author":"High","year":"2004","journal-title":"Semin Thromb Hemost"},{"key":"10.1136\/ard.2004.035063_bib16","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1128\/JVI.72.11.8568-8577.1998","article-title":"Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue","volume":"72","author":"Duan","year":"1998","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib17","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1128\/JVI.78.15.7874-7882.2004","article-title":"Adeno-associated virus site-specific integration and AAVS1 disruption","volume":"78","author":"Hamilton","year":"2004","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/mthe.2000.0219","article-title":"Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors","volume":"2","author":"Chao","year":"2000","journal-title":"Mol Ther"},{"key":"10.1136\/ard.2004.035063_bib19","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2003-02-0495","article-title":"Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy","volume":"102","author":"Grimm","year":"2003","journal-title":"Blood"},{"issue":"Pt 8","key":"10.1136\/ard.2004.035063_bib20","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1099\/0022-1317-81-8-2077","article-title":"Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors","volume":"81","author":"Handa","year":"2000","journal-title":"J Gen Virol"},{"key":"10.1136\/ard.2004.035063_bib21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<406::AID-JMV22>3.0.CO;2-N","article-title":"Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV)","volume":"59","author":"Erles","year":"1999","journal-title":"J Med Virol"},{"key":"10.1136\/ard.2004.035063_bib22","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/JVI.78.12.6344-6359.2004","article-title":"Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain","volume":"78","author":"Peden","year":"2004","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib24","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1089\/hum.1998.9.18-2745","article-title":"Novel tools for production and purification of recombinant adenoassociated virus vectors","volume":"9","author":"Grimm","year":"1998","journal-title":"Hum Gene Ther"},{"key":"10.1136\/ard.2004.035063_bib25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1525-0016(03)00095-9","article-title":"Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6","volume":"7","author":"Grimm","year":"2003","journal-title":"Mol Ther"},{"key":"10.1136\/ard.2004.035063_bib26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.gt.3300938","article-title":"Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield","volume":"6","author":"Zolotukhin","year":"1999","journal-title":"Gene Ther"},{"key":"10.1136\/ard.2004.035063_bib27","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4","article-title":"Inhibitor of nuclear factor kappaB kinase beta is a key regulator of synovial inflammation","volume":"44","author":"Tak","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.035063_bib28","first-page":"1118","article-title":"Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritis","volume":"25","author":"Nguyen","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.035063_bib29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/rheumatology\/39.1.43","article-title":"Quantification of the cell infiltrate in synovial tissue by digital image analysis","volume":"39","author":"Kraan","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2004.035063_bib30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/ard.60.3.296","article-title":"Measurement of cytokine and adhesion molecule expression in synovial tissue by digital image analysis","volume":"60","author":"Kraan","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.035063_bib31","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/art.10556","article-title":"Comparison of synovial tissues from the knee joints and the small joints of rheumatoid arthritis patients: implications for pathogenesis and evaluation of treatment","volume":"46","author":"Kraan","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.035063_bib32","first-page":"2089","article-title":"Analysis of serial synovial biopsies in patients with rheumatoid arthritis: description of a control group without clinical improvement after treatment with interleukin 10 or placebo","volume":"26","author":"Smeets","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2004.035063_bib33","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.4049\/jimmunol.146.10.3365","article-title":"Cytokines in chronic inflammatory arthritis. 6. Analysis of the synovial-cells involved in granulocyte-macrophage colony-stimulating factor production and gene-expression in rheumatoid-arthritis and its regulation by IL-1 and tumor-necrosis-factor-alpha","volume":"146","author":"Alvarogracia","year":"1991","journal-title":"J Immunol"},{"key":"10.1136\/ard.2004.035063_bib34","doi-asserted-by":"crossref","first-page":"10222","DOI":"10.1128\/JVI.72.12.10222-10226.1998","article-title":"Adeno-associated virus as a vector for liver-directed gene therapy","volume":"72","author":"Xiao","year":"1998","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1089\/10430349950018995","article-title":"Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression","volume":"10","author":"Lo","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1136\/ard.2004.035063_bib36","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1128\/JVI.73.4.3410-3417.1999","article-title":"Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model","volume":"73","author":"Pan","year":"1999","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib37","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JVI.72.2.1438-1445.1998","article-title":"Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions","volume":"72","author":"Summerford","year":"1998","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib38","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/8470","article-title":"Viral receptors and vector purification: new approaches for generating clinical-grade reagents","volume":"5","author":"Summerford","year":"1999","journal-title":"Nat Med"},{"key":"10.1136\/ard.2004.035063_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/4758","article-title":"Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2","volume":"5","author":"Qing","year":"1999","journal-title":"Nat Med"},{"key":"10.1136\/ard.2004.035063_bib40","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1128\/JVI.75.15.6884-6893.2001","article-title":"Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity","volume":"75","author":"Kaludov","year":"2001","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib41","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nm929","article-title":"Identification of PDGFR as a receptor for AAV-5 transduction","volume":"9","author":"Di Pasquale","year":"2003","journal-title":"Nat Med"},{"key":"10.1136\/ard.2004.035063_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/ard.39.3.241","article-title":"DNA synthesis in human rheumatoid and nonrheumatoid synovial lining","volume":"39","author":"Coulton","year":"1980","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2004.035063_bib43","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/JVI.74.4.1761-1766.2000","article-title":"Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure","volume":"74","author":"Moskalenko","year":"2000","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib44","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/JVI.74.5.2420-2425.2000","article-title":"Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle","volume":"74","author":"Chirmule","year":"2000","journal-title":"J Virol"},{"key":"10.1136\/ard.2004.035063_bib45","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J Virol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724203551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724203551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.035063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:38:37Z","timestamp":1737333517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724203551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0003496724203551"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.035063","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.035063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}